We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
-6.47%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.69%
AUM
$14.1B
AUM Growth
-$2.27B
(-14%)
Cap. Flow
-$900M
Cap. Flow
% of AUM
-6.37%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
310
New
28
Increased
101
Reduced
110
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$225M |
| 2 |
Lowe's Companies
LOW
|
+$182M |
| 3 |
Yum! Brands
YUM
|
+$171M |
| 4 |
Amazon
AMZN
|
+$143M |
| 5 |
Steris
STE
|
+$99.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$253M |
| 2 |
Citigroup
C
|
+$243M |
| 3 |
Viatris
VTRS
|
+$151M |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$150M |
| 5 |
Whirlpool
WHR
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.37% |
| 2 | Consumer Discretionary | 17.52% |
| 3 | Technology | 15.79% |
| 4 | Industrials | 11.57% |
| 5 | Communication Services | 10.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
AstraZeneca
AZN
$248B
| $6.07M | 0.04% |
+95,450
| New | +$6.28M |
|
202
GSK
GSK
$104B
| $6.03M | 0.04% |
125,472
+37,064
| +42% | +$1.93M |
|
203
CME Group
CME
$94.9B
| $5.65M | 0.04% |
+60,970
| New | +$5.8M |
|
204
Jack Henry & Associates
JKHY
$11.1B
| $5.46M | 0.04% |
78,372
-290
| -0.4% | -$19.9K |
|
205
Bank of America
BAC
$440B
| $5.35M | 0.04% |
343,650
+285,300
| +489% | +$4.8M |
|
|
AGN
206
DELISTED
Allergan plc
AGN
| $5.25M | 0.04% |
19,330
-822,042
| -98% | -$253M |
|
207
Paychex
PAYX
$42.5B
| $5.19M | 0.04% |
109,012
-350
| -0.3% | -$16.3K |
|
208
Lennar Class A
LEN
$20.4B
| $4.97M | 0.04% |
108,423
| – | – |
|
209
Pfizer
PFE
$148B
| $4.61M | 0.03% |
154,732
-475
| -0.3% | -$15.2K |
|
210
Flowers Foods
FLO
$1.53B
| $4.56M | 0.03% |
+184,420
| New | +$4.19M |
|
|
PACW
211
DELISTED
PacWest Bancorp
PACW
| $4.45M | 0.03% |
104,050
-40
| -0% | -$1.79K |
|
212
Boeing
BA
$184B
| $4.4M | 0.03% |
33,630
+800
| +2% | +$111K |
|
213
Keurig Dr Pepper
KDP
$41.5B
| $4.24M | 0.03% |
53,591
-210
| -0.4% | -$16.5K |
|
214
PepsiCo
PEP
$188B
| $4.21M | 0.03% |
44,602
-140
| -0.3% | -$13.3K |
|
215
Collegium Pharmaceutical
COLL
$973M
| $4.08M | 0.03% |
+184,461
| New | +$3.34M |
|
216
Kimberly-Clark
KMB
$36.2B
| $3.98M | 0.03% |
36,531
-100
| -0.3% | -$11K |
|
217
Copart
CPRT
$26.5B
| $3.18M | 0.02% |
772,880
-4,588,544
| -86% | -$20.3M |
|
218
CVS Health
CVS
$123B
| $2.58M | 0.02% |
26,700
| – | – |
|
219
Rapid7
RPD
$694M
| $2.56M | 0.02% |
+112,470
| New | +$2.5M |
|
220
Danaher
DHR
$139B
| $2.27M | 0.02% |
39,612
| – | – |
|
221
Allison Transmission
ALSN
$9.74B
| $2.02M | 0.01% |
75,550
-1,131,135
| -94% | -$32.4M |
|
222
iShares Core S&P US Growth ETF
IUSG
$33.4B
| $1.32M | 0.01% |
+34,776
| New | +$1.4M |
|
223
iShares Russell 2000 Growth ETF
IWO
$14.9B
| $1.25M | 0.01% |
+9,300
| New | +$1.38M |
|
224
Skyworks Solutions
SWKS
$10B
| $1.16M | 0.01% |
13,760
-163,290
| -92% | -$14.9M |
|
225
GE Aerospace
GE
$390B
| $1.11M | 0.01% |
9,202
| – | – |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q3 2015 Portfolio in Review
As of Q3 2015, Westfield Capital Management held 310 positions worth $14.1B, down 14% from $16.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Westfield Capital Management withdrew a net $900M in Q3 2015, closing 49 positions and reducing 110 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $150M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Westfield Capital Management opened a new position in Lowe's Companies worth $182M.
- Westfield Capital Management's largest Q3 2015 buy was Lowe's Companies: 2,647,293 shares worth $182M.
- Westfield Capital Management added most to Vertex Pharmaceuticals in Q3 2015, an estimated $225M increase.
- Westfield Capital Management's biggest Q3 2015 reduction was Allergan plc, cutting an estimated $253M.
- Westfield Capital Management fully exited PRECISION CASTPARTS CORP in Q3 2015, selling an estimated $150M.
- Westfield Capital Management's ten largest holdings make up 19% of its $14.1B portfolio in Q3 2015.
- Westfield Capital Management opened 28 new positions and closed 49 in Q3 2015.
- Westfield Capital Management's portfolio value fell 14% quarter-over-quarter to $14.1B.
Based on Westfield Capital Management's 13F filing for Q3 2015, filed 12 Nov 2015.